Motor Cortex Stimulation for Facial Pain

Zoe E. Teton, Ahmed M. Raslan

Research output: Contribution to journalArticlepeer-review


Motor cortex stimulation (MCS) has been used in the treatment of intractable neuropathic facial pain for nearly 30 years. While efficacy rates have been noted as high as 88% in some studies, considerable variability in treatment response remains. Additionally, MCS is often cited as providing diminishing relief over time, and there are few long-term studies on efficacy. Complications are generally mild and include infection, hardware complication, seizure, and transient neurological deficit. Despite relatively minimal use, MCS remains a viable treatment option for the appropriately selected facial pain patients that have proved refractory to conservative management.

Original languageEnglish (US)
Pages (from-to)162-169
Number of pages8
JournalProgress in Neurological Surgery
StatePublished - 2020

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology


Dive into the research topics of 'Motor Cortex Stimulation for Facial Pain'. Together they form a unique fingerprint.

Cite this